Hologic (HOLX) Competitors $78.97 +0.25 (+0.32%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends HOLX vs. PHG, QGEN, BDX, EW, RMD, IDXX, DXCM, STE, PODD, and BAXShould you be buying Hologic stock or one of its competitors? The main competitors of Hologic include Koninklijke Philips (PHG), Qiagen (QGEN), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Insulet (PODD), and Baxter International (BAX). These companies are all part of the "medical" sector. Hologic vs. Koninklijke Philips Qiagen Becton, Dickinson and Company Edwards Lifesciences ResMed IDEXX Laboratories DexCom STERIS Insulet Baxter International Koninklijke Philips (NYSE:PHG) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, community ranking, dividends, profitability, earnings, media sentiment, valuation and risk. Does the MarketBeat Community favor PHG or HOLX? Hologic received 498 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 69.67% of users gave Hologic an outperform vote while only 56.56% of users gave Koninklijke Philips an outperform vote. CompanyUnderperformOutperformKoninklijke PhilipsOutperform Votes37556.56% Underperform Votes28843.44% HologicOutperform Votes87369.67% Underperform Votes38030.33% Which has stronger valuation & earnings, PHG or HOLX? Hologic has lower revenue, but higher earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKoninklijke Philips$19.66B1.26-$503.27M-$0.42-62.84Hologic$4.03B4.55$789.50M$3.3323.71 Which has more volatility & risk, PHG or HOLX? Koninklijke Philips has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Do analysts recommend PHG or HOLX? Hologic has a consensus target price of $89.91, indicating a potential upside of 13.85%. Given Hologic's stronger consensus rating and higher probable upside, analysts clearly believe Hologic is more favorable than Koninklijke Philips.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20Hologic 0 Sell rating(s) 4 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is PHG or HOLX more profitable? Hologic has a net margin of 19.59% compared to Koninklijke Philips' net margin of -1.83%. Hologic's return on equity of 19.79% beat Koninklijke Philips' return on equity.Company Net Margins Return on Equity Return on Assets Koninklijke Philips-1.83% 10.11% 4.12% Hologic 19.59%19.79%11.00% Do institutionals and insiders hold more shares of PHG or HOLX? 13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 94.7% of Hologic shares are owned by institutional investors. 1.8% of Hologic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to PHG or HOLX? In the previous week, Hologic had 5 more articles in the media than Koninklijke Philips. MarketBeat recorded 11 mentions for Hologic and 6 mentions for Koninklijke Philips. Hologic's average media sentiment score of 1.05 beat Koninklijke Philips' score of 0.62 indicating that Hologic is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hologic 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHologic beats Koninklijke Philips on 17 of the 18 factors compared between the two stocks. Ad Insiders Exposed917 Trades… Zero Losses?As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Get Hologic News Delivered to You Automatically Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOLX vs. The Competition Export to ExcelMetricHologicX IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.34B$13.65B$5.38B$8.84BDividend YieldN/A1.84%5.14%4.09%P/E Ratio23.7123.18105.9717.81Price / Sales4.5511.071,246.69162.50Price / Cash14.2812.9640.3436.29Price / Book3.572.627.086.50Net Income$789.50M$273.70M$119.65M$226.10M7 Day Performance0.47%9.42%2.15%3.98%1 Month Performance-3.20%3.46%-3.13%3.78%1 Year Performance9.41%31.55%33.79%29.29% Hologic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOLXHologic4.8988 of 5 stars$78.97+0.3%$89.91+13.9%+9.4%$18.34B$4.03B23.716,990Positive NewsPHGKoninklijke Philips2.691 of 5 stars$26.38+0.3%N/A+24.7%$24.80B$19.66B0.0069,656QGENQiagen4.2795 of 5 stars$42.33+0.6%$50.88+20.2%+2.1%$9.66B$1.97B108.385,967BDXBecton, Dickinson and Company4.9897 of 5 stars$225.21+1.3%$283.00+25.7%-5.4%$65.10B$20.18B37.9473,000Positive NewsEWEdwards Lifesciences4.1597 of 5 stars$70.56+1.5%$75.67+7.2%+5.1%$41.61B$6.00B10.0319,800Analyst RevisionRMDResMed4.8188 of 5 stars$243.60+0.8%$225.70-7.3%+59.7%$35.76B$4.69B31.999,980Positive NewsIDXXIDEXX Laboratories4.8664 of 5 stars$419.37+0.2%$552.38+31.7%-12.8%$34.34B$3.66B40.3711,000News CoveragePositive NewsGap DownDXCMDexCom4.9853 of 5 stars$74.48-1.0%$104.59+40.4%-34.3%$29.09B$3.62B45.059,600Insider TradeNews CoveragePositive NewsSTESTERIS4.9927 of 5 stars$215.77+1.7%$253.00+17.3%+5.8%$21.30B$5.14B48.4618,179Ex-DividendPositive NewsHigh Trading VolumePODDInsulet4.4129 of 5 stars$262.99-1.3%$253.27-3.7%+41.1%$18.45B$1.70B45.033,000News CoveragePositive NewsBAXBaxter International4.4971 of 5 stars$33.12+1.5%$40.91+23.5%-7.4%$16.91B$14.81B165.4660,000 Related Companies and Tools Related Companies Koninklijke Philips Alternatives Qiagen Alternatives Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives ResMed Alternatives IDEXX Laboratories Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HOLX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
